US3507911A - Di-substituted malonic acids - Google Patents
Di-substituted malonic acids Download PDFInfo
- Publication number
- US3507911A US3507911A US577559A US3507911DA US3507911A US 3507911 A US3507911 A US 3507911A US 577559 A US577559 A US 577559A US 3507911D A US3507911D A US 3507911DA US 3507911 A US3507911 A US 3507911A
- Authority
- US
- United States
- Prior art keywords
- malonic acid
- bis
- diethyl ester
- chlorophenoxy
- acid diethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 Di-substituted malonic acids Chemical class 0.000 title description 56
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 59
- 238000000034 method Methods 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- 150000001875 compounds Chemical class 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 21
- 239000002253 acid Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000725 suspension Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 229940031826 phenolate Drugs 0.000 description 10
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 9
- KJGZMGQUWSSZTD-UHFFFAOYSA-N diethyl 2,2-bis(4-chlorophenoxy)propanedioate Chemical compound C(C)OC(C(C(=O)OCC)(OC1=CC=C(C=C1)Cl)OC1=CC=C(C=C1)Cl)=O KJGZMGQUWSSZTD-UHFFFAOYSA-N 0.000 description 9
- 229910052736 halogen Inorganic materials 0.000 description 9
- 150000002367 halogens Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 150000004707 phenolate Chemical class 0.000 description 8
- 239000012312 sodium hydride Substances 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 7
- 239000003208 petroleum Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- MTBXQWQXBWXCQD-UHFFFAOYSA-N 2,2-bis(4-chlorophenoxy)propanedioic acid Chemical compound ClC1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)Cl)C=C1 MTBXQWQXBWXCQD-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 5
- 229910001863 barium hydroxide Inorganic materials 0.000 description 5
- 159000000009 barium salts Chemical class 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- YXVFYQXJAXKLAK-UHFFFAOYSA-N biphenyl-4-ol Chemical compound C1=CC(O)=CC=C1C1=CC=CC=C1 YXVFYQXJAXKLAK-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- XXBPHNOSWYWBKC-UHFFFAOYSA-N 2,2-bis(2,4-dichlorophenoxy)propanedioic acid Chemical compound ClC1=C(OC(C(=O)O)(C(=O)O)OC2=C(C=C(C=C2)Cl)Cl)C=CC(=C1)Cl XXBPHNOSWYWBKC-UHFFFAOYSA-N 0.000 description 3
- YEXLSADGGGZMRF-UHFFFAOYSA-N 2,2-bis(4-bromophenoxy)propanedioic acid Chemical compound BrC1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)Br)C=C1 YEXLSADGGGZMRF-UHFFFAOYSA-N 0.000 description 3
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- BYKNUFUVNDXNMA-UHFFFAOYSA-N diethyl 2,2-bis(2-chlorophenoxy)propanedioate Chemical compound C(C)OC(C(C(=O)OCC)(OC1=C(C=CC=C1)Cl)OC1=C(C=CC=C1)Cl)=O BYKNUFUVNDXNMA-UHFFFAOYSA-N 0.000 description 3
- XDBWHJFJTATCSZ-UHFFFAOYSA-N diethyl 2,2-bis(3-chlorophenoxy)propanedioate Chemical compound C(C)OC(C(C(=O)OCC)(OC1=CC(=CC=C1)Cl)OC1=CC(=CC=C1)Cl)=O XDBWHJFJTATCSZ-UHFFFAOYSA-N 0.000 description 3
- UFYCAUSUVBXKHC-UHFFFAOYSA-N diethyl 2,2-bis(4-fluorophenoxy)propanedioate Chemical compound C(C)OC(C(C(=O)OCC)(OC1=CC=C(C=C1)F)OC1=CC=C(C=C1)F)=O UFYCAUSUVBXKHC-UHFFFAOYSA-N 0.000 description 3
- 150000002691 malonic acids Chemical class 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- JEYQVOOTZIODRO-UHFFFAOYSA-N 2,2-bis(2-chlorophenoxy)propanedioic acid Chemical compound ClC1=C(OC(C(=O)O)(C(=O)O)OC2=C(C=CC=C2)Cl)C=CC=C1 JEYQVOOTZIODRO-UHFFFAOYSA-N 0.000 description 2
- KCDNXCMIYVJOBV-UHFFFAOYSA-N 2,2-bis(3-chlorophenoxy)propanedioic acid Chemical compound ClC=1C=C(OC(C(=O)O)(C(=O)O)OC2=CC(=CC=C2)Cl)C=CC1 KCDNXCMIYVJOBV-UHFFFAOYSA-N 0.000 description 2
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 2
- GKGUEGLMHGRSCQ-UHFFFAOYSA-N 2-(4-chlorophenoxy)-2-(4-fluorophenoxy)propanedioic acid Chemical compound ClC1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)F)C=C1 GKGUEGLMHGRSCQ-UHFFFAOYSA-N 0.000 description 2
- HJSPWKGEPDZNLK-UHFFFAOYSA-N 4-benzylphenol Chemical compound C1=CC(O)=CC=C1CC1=CC=CC=C1 HJSPWKGEPDZNLK-UHFFFAOYSA-N 0.000 description 2
- NWSIFTLPLKCTSX-UHFFFAOYSA-N 4-chloro-2-nitrophenol Chemical compound OC1=CC=C(Cl)C=C1[N+]([O-])=O NWSIFTLPLKCTSX-UHFFFAOYSA-N 0.000 description 2
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- WACQKHWOTAEEFS-UHFFFAOYSA-N cyclohexane;ethyl acetate Chemical compound CCOC(C)=O.C1CCCCC1 WACQKHWOTAEEFS-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- OGAQUEVCMKCQCB-UHFFFAOYSA-N diethyl 2,2-bis(3,4-dichlorophenoxy)propanedioate Chemical compound C=1C=C(Cl)C(Cl)=CC=1OC(C(=O)OCC)(C(=O)OCC)OC1=CC=C(Cl)C(Cl)=C1 OGAQUEVCMKCQCB-UHFFFAOYSA-N 0.000 description 2
- CVUWIDHMPAIDPN-UHFFFAOYSA-N diethyl 2,2-bis(4-bromophenoxy)propanedioate Chemical compound C(C)OC(C(C(=O)OCC)(OC1=CC=C(C=C1)Br)OC1=CC=C(C=C1)Br)=O CVUWIDHMPAIDPN-UHFFFAOYSA-N 0.000 description 2
- PFZYFZRUPFUEOB-UHFFFAOYSA-N diethyl 2,2-dibromopropanedioate Chemical compound CCOC(=O)C(Br)(Br)C(=O)OCC PFZYFZRUPFUEOB-UHFFFAOYSA-N 0.000 description 2
- JJQHMFJEJRHLGI-UHFFFAOYSA-N diethyl 2-(4-chlorophenoxy)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)OC1=CC=C(Cl)C=C1 JJQHMFJEJRHLGI-UHFFFAOYSA-N 0.000 description 2
- WKYHKYRYDDSPPE-UHFFFAOYSA-N diethyl 2-(4-fluorophenoxy)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)OC1=CC=C(F)C=C1 WKYHKYRYDDSPPE-UHFFFAOYSA-N 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CTHVDALIQPUTKF-UHFFFAOYSA-N 2,2-bis(2,5-dichlorophenoxy)propanedioic acid Chemical compound ClC1=C(OC(C(=O)O)(C(=O)O)OC2=C(C=CC(=C2)Cl)Cl)C=C(C=C1)Cl CTHVDALIQPUTKF-UHFFFAOYSA-N 0.000 description 1
- UHRGRAPFYJSYKI-UHFFFAOYSA-N 2,2-bis(3,5-dichlorophenoxy)propanedioic acid Chemical compound ClC=1C=C(OC(C(=O)O)(C(=O)O)OC2=CC(=CC(=C2)Cl)Cl)C=C(C1)Cl UHRGRAPFYJSYKI-UHFFFAOYSA-N 0.000 description 1
- DCSSYQWECJTMAW-UHFFFAOYSA-N 2,2-bis(4-acetamidophenoxy)propanedioic acid Chemical compound C(C)(=O)NC1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)NC(C)=O)C=C1 DCSSYQWECJTMAW-UHFFFAOYSA-N 0.000 description 1
- TUEBXOMXMFBEGJ-UHFFFAOYSA-N 2,2-bis(4-benzoylphenoxy)propanedioic acid Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)C(C2=CC=CC=C2)=O)C=C1 TUEBXOMXMFBEGJ-UHFFFAOYSA-N 0.000 description 1
- RESVTEBRYXSTBS-UHFFFAOYSA-N 2,2-bis(4-benzylphenoxy)propanedioic acid Chemical compound C(C1=CC=CC=C1)C1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)CC2=CC=CC=C2)C=C1 RESVTEBRYXSTBS-UHFFFAOYSA-N 0.000 description 1
- IXXZDXHQCSDFHZ-UHFFFAOYSA-N 2,2-bis(4-chloro-2-methylphenoxy)propanedioic acid Chemical compound ClC1=CC(=C(OC(C(=O)O)(C(=O)O)OC2=C(C=C(C=C2)Cl)C)C=C1)C IXXZDXHQCSDFHZ-UHFFFAOYSA-N 0.000 description 1
- BJTCRYCRGSFEOE-UHFFFAOYSA-N 2,2-bis(4-chloro-2-nitrophenoxy)propanedioic acid Chemical compound ClC1=CC(=C(OC(C(=O)O)(C(=O)O)OC2=C(C=C(C=C2)Cl)[N+](=O)[O-])C=C1)[N+](=O)[O-] BJTCRYCRGSFEOE-UHFFFAOYSA-N 0.000 description 1
- ATDAPBZDAWWEJE-UHFFFAOYSA-N 2,2-bis[4-(trifluoromethyl)phenoxy]propanedioic acid Chemical compound FC(C1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)C(F)(F)F)C=C1)(F)F ATDAPBZDAWWEJE-UHFFFAOYSA-N 0.000 description 1
- RDCDTXVNFSHGGK-UHFFFAOYSA-N 2-(4-bromophenoxy)-2-(4-chlorophenoxy)propanedioic acid Chemical compound ClC1=CC=C(OC(C(=O)O)(C(=O)O)OC2=CC=C(C=C2)Br)C=C1 RDCDTXVNFSHGGK-UHFFFAOYSA-N 0.000 description 1
- GZMFZHIPGZSUHI-UHFFFAOYSA-N 2-(4-bromophenoxy)propanedioic acid Chemical compound OC(=O)C(C(O)=O)OC1=CC=C(Br)C=C1 GZMFZHIPGZSUHI-UHFFFAOYSA-N 0.000 description 1
- UHXFDOLEGHANHH-UHFFFAOYSA-N 2-(4-chlorophenoxy)propanedioic acid Chemical compound OC(=O)C(C(O)=O)OC1=CC=C(Cl)C=C1 UHXFDOLEGHANHH-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- WDNBURPWRNALGP-UHFFFAOYSA-N 3,4-Dichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1 WDNBURPWRNALGP-UHFFFAOYSA-N 0.000 description 1
- VPOMSPZBQMDLTM-UHFFFAOYSA-N 3,5-dichlorophenol Chemical compound OC1=CC(Cl)=CC(Cl)=C1 VPOMSPZBQMDLTM-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- QASBCTGZKABPKX-UHFFFAOYSA-N 4-(methylsulfanyl)phenol Chemical compound CSC1=CC=C(O)C=C1 QASBCTGZKABPKX-UHFFFAOYSA-N 0.000 description 1
- NPFYZDNDJHZQKY-UHFFFAOYSA-N 4-Hydroxybenzophenone Chemical compound C1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 NPFYZDNDJHZQKY-UHFFFAOYSA-N 0.000 description 1
- XAYCNCYFKLSMGR-UHFFFAOYSA-N 4-phenylsulfanylphenol Chemical compound C1=CC(O)=CC=C1SC1=CC=CC=C1 XAYCNCYFKLSMGR-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000002905 alkanoylamido group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- WLWCQKMQYZFTDR-UHFFFAOYSA-N diethyl 2-chloropropanedioate Chemical compound CCOC(=O)C(Cl)C(=O)OCC WLWCQKMQYZFTDR-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/58—Preparation of carboxylic acid halides
- C07C51/60—Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Definitions
- the substituents include trifiuoromethyl, (lower)alkanoylamido, (lower) alkylthio, cyc1o(1ower)alkyl, phenyl, phenoxy, phenylthio, anilino, benzoyl, phenyl(lower)alkyl, halogen, (lower) alkyl and nitro.
- This invention relates to derivatives of malonic acid.
- the invention is concerned with di-substituted malonic acids of the formula wherein:
- A is either B is when A is either (X1)!!! Z1 C or B is whenA is R is hydrogen; trifluoromethyl; loweralkanoylamido, preferably containing from 2 to 4 carbon atoms, e.g., acetamido, propionamido and butyrylamido; loweralkylthio, preferably containing from 1 to 4 carbon atoms, e.g., methylthio, ethylthio, propylthio and butylthio; cycloloweralkyl, preferably containing from 5 to 7 carbon atoms, e.g., cyclopentyl, cyclohexyl and cycloheptyl; or an aromatic moiety of the formula R is trifluoromethyl; loweralkanoylamido, preferably containing from 2 to 4 carbon atoms, e.g., acetamido, propionamido and butyrylamido; loweralkylthio,
- X and X are the same or different and represent halogen, preferably having an atomic weight no greater than 80, i.e., fluorine, bromine or chlorine;
- Z and Z are the same or different and represent loweralkyl, preferably containing from 1 to 4 carbon atoms, e.g., methyl, ethyl, propyl and butyl; or nitro; and
- n and n are the same or different and represent a whole number of from 1 to 3, inclusive or A and B are both m-trifluoromethylphenyl.
- the preferred compounds of the present invention are those compounds of structural Formula I wherein A and B are the same, e.g., bis-(p-chlorophenoxy)malonic acid.
- the above compounds (I) are prepared by reacting a di-substituted malonic acid ester with barium hydroxide to form a barium salt of the free acid and then converting the latter to the free acid. This process may be illustrated as follows:
- a and B are as defined above;
- R represents lower alkyl, preferably containing from 1 to 4 carbon atoms, e.g., methyl, ethyl, propyl, isopropyl, butyl and t-butyl.
- the reaction of the malonic acid ester (II) with barium hydroxide is carried out in a suitable inert solvent system which is capable of solubilizing both the barium hydroxide and the malonic acid ester.
- the solvent system is composed of a mixture of Water and an organic solvent containing such amounts of each as may be necessary to solubilize the barium hydroxide and malonic acid ester, respectively.
- the particular organic solvent employed is not critical and the selection thereof is dependent upon the degree of solubility of the particular malonic acid ester in said solvent. However, it is preferred to employ an organic solvent which is water-miscible.
- Suitable solvents include the lower alkanols, e.g., methanol and ethanol, and others, e.g., diethyl ether, dioxane and tetrahydrofuran.
- the temperature at which the reaction is carried out is critical to the extent that elevated temperatures (i.e., above about 35 C.) should. not be employed.
- the reaction is effected at ordinary room temperature (2025 C.) although lower temperatures can be utilized.
- the resulting insoluble barium salt can be readily recovered in conventional manner.
- the malonic acid (I) is obtained by reacting the thusobtained barium salt with a strong acid at room temperature.
- This reaction is conveniently carried out in any suitable inert organic solvent such as a lower alkanol, e.g., methanol.
- the solvent is one which is capable of solubilizing the free malonic acid and in which the barium salt, formed during the reaction with the strong acid, is insoluble.
- the acid employed is a mineral acid, preferably sulfuric acid. Recovery of the free malonic acid is accomplished in conventional manner.
- the malonic acid esters (II) employed as starting materials may be prepared by reacting an unsubstituted or appropriately substituted phenolate with an appropriately substituted malonic acid to form the corresponding substituted malonic acid ester derivative.
- the resulting product is then treated with a halogenating agent to form the corresponding a-halo-derivati've and the latter reacted with an appropriately substituted phenolate to form the desired product.
- This process may be represented strncturally as follows:
- Step 1 Cl /I-Ialogenating Agent K Step 2 A-ONa Step 3
- Hal represents halogen, preferably chlorine or bromine.
- Step 1 of the process invovles the reaction of the phenolate or substituted phenolate with a chloromalonic acid ester to form the corresponding substituted malonic acid ester derivative.
- This reaction is conveniently carried out in a suitable inert organic solvent such as dimethylacetamide, diethylacetamide, dimethylformamide or tetramethylurea.
- a suitable inert organic solvent such as dimethylacetamide, diethylacetamide, dimethylformamide or tetramethylurea.
- the reaction is initially carried out at elevated temperatures up to about 80 C. and then allowed to continue at room temperature.
- the particular solvent employed is not critical.
- the particular temperature employer is not critical provided it does not exceed about 80 C.
- the substituted malonic acid ester derivative is halogenated employing conventional agents for this purpose.
- the preferred agent is bromine, however, other agents such as chlorine, N-bromo-succinimide or sulfuryl chloride can also be used.
- the halogenation is conveniently carried out in a suitable inert organic solvent such as a haloalkane for example, dichloromcthane, chloroform, carbon tetrachloride and the like.
- a suitable inert organic solvent such as a haloalkane for example, dichloromcthane, chloroform, carbon tetrachloride and the like.
- the reaction is initially carried out at room temperature and then allowed to continue at reflux temperature.
- solvent neither the choice of solvent nor temperature employed is critical.
- Step 3 involves the reaction of the a-halo-derivative obtained in Step 2 With the appropriately substituted phenolate.
- This reaction is conveniently effected in a suitable inert organic solvent such as that employed in Step 1.
- a suitable inert organic solvent such as that employed in Step 1.
- this reaction is initially carried out at room temperature and then allowed to continue at elevated temperatures up to about C.
- the choice of solvent or temperature employed is not critical provided that with respect to the latter, it does not exceed about 80 C.
- the resulting malonic acid ester (II) is readily recoverable employing conventional techniques.
- the malonic acid esters of structural Formula H wherein A and B are the same may also be prepared by reacting an appropriately substituted phenolate with a dihalomalonic acid ester. This process may be illustrated structurally as follows:
- A is m-trifluoromethylphenyl R, X', Z, R", Hal and n are as defined hereinabove.
- the phenolates employed in the above process can be prepared as described in the literature or in analogous manner.
- the statement above regarding the preparation of the phenolates employing sodium hydride is equally applicable to the instant process.
- Various of the dihalomalonic acid esters employed are likewise known and can be prepared as described in the literature. Such others which are not specifically known can be prepared from available materials in analogous manner.
- the compounds of structural Formula I are useful because they possess pharmacological activity.
- the compounds are useful as hypocholesteremics/hypolipemics.
- the compounds may be admixed with conventional pharmaceutical carriers, and other adjuvants, if necessary, and administered orally in such forms as tablets, capsules, elixirs, suspensions or solutions.
- the compounds may be similarly administered in the form of their sodium or calcium salts.
- Such salts do not materially differ from the base in their pharmacological effects and are included within the scope of the invention.
- the salts are readily prepared by reacting the acid with an appropriate base in conventional manner. The dosage administered will, of course, vary depending on the compound employed.
- a representative formulation suitable for oral administration is a tablet prepared by standard tabletting techniques and containing (by weight) 50 parts of bis-(p-chlorophenoxy) malonic acid, 2 parts of tragacanth, 39.5 parts of lactose, 5 parts of corn starch, 3 parts of talcum and 0.5 part of magnesium stearate.
- Step B Preparation of bis-(p-chlorophenoxy)malonic ac1d.
- To the practically-clear solution add a solution of 20.65 parts (0.05 mole) of bis-(p-chlorophenoxy)malonic acid diethyl ester in 50 parts by volume of methanol.
- a very thick, white suspension forms almost immediately. Keep the suspension on the water bath for 15 minutes, then filter off the solids (barium salt) and dry the same in an oven under high vacuum.
- the formed suspension of the phenolate is stirred for an additional hour. Then remove the cooling bath, and add 159 parts (0.5 mole) of diethyldibromomalonate fairly rapidly to said formed suspension, allowing the temperature to rise about 32.
- Step B Preparation of bis-(4-biphenylyloxy)malonic acid.Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(4-biphenylyloxy)malonic acid diethyl ester in place of the bis-(pchlorophenoxy).malonic acid diethyl ester used therein, there is obtained the product 'bis-(4-biphenylyloxy)malonic acid.
- Step B Preparation of bis-(p-bromophenoxy)malonic acid.-Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(p-brornophenoxy)malo nic acid diethyl ester in place of the bis- (p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(p-bromophenoxy) malonic acid.
- Step B Preparation of bis-(p-fluorophenoxy)malonic acid.Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(p-fluorophenoxy)malonic acid diethyl ester in place of the bis-(pchlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(p-fluorophenoxy)malonic acid.
- Step B Preparation of bis-(m-chlorophenoxy)malonic acid.FolloWing the procedure of Step B of Example 1 and employing an equivalent amount of bis-(m-chlorophenoxy)malonic acid diethyl ester in place of the bis- (p-chlorophenoxy)malonic acid diethyl ester used there in, there is obtained the product bis-(m-chlorophenoxy)- malonic acid.
- Step B Preparation of bis-(3,4-dichlorophenoxy) malonic acid-Following the procedure of Step B of Example 1 and employing an equivalent amount of bis- (3,4-dichlorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(3,4- dichlorophenoxy)malonic acid.
- Step B Preparation of bis-(o-chlorophenoxy)malonic acid.FolloWing the procedure of Step B of Example 1 and employing an equivalent amount of bis-(o-chlorophenoxy)malonic acid diethyl ester in place of the his- (p-ch1orophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis(o-chlorophenoxy) malonic acid, M.P. 143 C. (dec.).
- Malonic acid ester Malonic acid (a) Bis-(p-trifluoromethylphenoxy) Bis-(p-trifluoromethylphenoxy) malonic acid diethyl ester. malonic acid.
- esters are prepared following the procedure of Step A of Example 1 and employing an equivalent amount of the phenols set forth below in place of the p-chlorophenol used therein.
- Step B Preparation of (4-biphenylyloxy)-(p-chl0rophenoxy malonic acid.-F0l0wing the procedure of Step B of Example 1 and employing an equivalent amount of (4-biphenylyloxy)- (p-chlorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product (4-biphenylyloxy) p-chlorophenoxy) malonic acid.
- EXAMPLE 12 (p-Chlorophenoxy)-(p-bromophenoxy)malonic acid 1 1
- EXAMPLE 13 (p-Chlorophenoxy)-(p-fluorophenoxy) malonic acid
- Step A Preparation of (p-chlorophenoxy)-(p-fluorophenoxy)malonic acid diethyl ester.Following the procedure of Step A of Example 11 and employing an equivalent amount of p-fluorophenol in place of the p-phenylphenol used therein, there is obtained the product (pchlorophenoxy) (p-fluorophenoxy)malonic acid diethyl ester, B.P. 160 C./0.25 mm. Crystallization from petroleum ether affords crystalline product, M.P. 40-41 C.
- Step B Preparation of (p-chlorophenoxy)-(pfluorophenoxy)malonic acid.--Following the procedure of Step B of Example 1 and employing an equivalent of (pchlorophenoxy) (p-fluorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester, there is obtained the product (p-chlorophenoxy) (p-fluorophenoxy) malonic acid.
- esters are prepared following the procedure of Step A of Example 1 and employing an equivalent amount of the phenols set forth below in place of the p-chlorophenol used therein.
- Y is either a direct bond or a bridging member of the group oxygen, sulfur, imino, carbonyl or straight chain alkylene, having from 1 to 4 carbon atoms;
- B is either the same as A; or B is When A is either wherein X and n are as defined above, and X represents halogen which is unlike X.
- n is as defined in claim 1, with the provision that any of X and X represents halogen having an atomic weight no greater than 80.
- n is as defined in claim 1, with the provision that X represents halogen having an atomic weight no greater than 80.
- a compound of claim 2 which is bis-(p-benzylphenoxy)malonic acid, bis-(p-acetamidophenoxy)malonic acid, or bis-(p-benzoylphenoxy)malonic acid.
- a compound of claim 2 which is bis-(p-fluorophenoxy)malonic acid, bis-(o chlorophenoxy)malonic acid, bis-(2,5-dichlorophenoxy)malonic acid, bis-(2,3- dichlorophenoxy) malonic acid and bis-(3,5-dichlorophenoxy)malonic acid.
- a compound of claim 2 which is bis-(4-chloro-2- nitrophenoxy)malonic acid, or bis-(4-chloro-2-methylphenoxy)malonic acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
United States Patent 3,507,911 DI-SUBSTITUTED MALONIC ACIDS Rudolf G. Griot and Johann R. Oetterli, Florham Park, N.J., assignors to Sandoz-Wander, Inc., Hanover, N.J., a corporation of Delaware No Drawing. Continuation-impart of abandoned application Ser. No. 547,771, May 5, 1966. This application Aug. 2, 1966, Ser. No. 577,559
Int. Cl. C07c 65/14 US. Cl. 260-520 22 Claims ABSTRACT OF THE DISCLOSURE The compounds are useful therapeutically as hypocholestermics/hypolipemics and have the formula A may be phenyl or substituted phenyl and B is sub stituted phenyl which otherwise may be like or unlike A, e.g., bis(p-chlorophenoxy)ma1onic acid. The substituents include trifiuoromethyl, (lower)alkanoylamido, (lower) alkylthio, cyc1o(1ower)alkyl, phenyl, phenoxy, phenylthio, anilino, benzoyl, phenyl(lower)alkyl, halogen, (lower) alkyl and nitro.
This application is a continuation-in-part of our copending application Ser. No. 547,771, filed May 5, 1966, now abandoned.
This invention relates to derivatives of malonic acid. In particular, the invention is concerned with di-substituted malonic acids of the formula wherein:
A is either B is when A is either (X1)!!! Z1 C or B is whenA is R is hydrogen; trifluoromethyl; loweralkanoylamido, preferably containing from 2 to 4 carbon atoms, e.g., acetamido, propionamido and butyrylamido; loweralkylthio, preferably containing from 1 to 4 carbon atoms, e.g., methylthio, ethylthio, propylthio and butylthio; cycloloweralkyl, preferably containing from 5 to 7 carbon atoms, e.g., cyclopentyl, cyclohexyl and cycloheptyl; or an aromatic moiety of the formula R is trifluoromethyl; loweralkanoylamido, preferably containing from 2 to 4 carbon atoms, e.g., acetamido, propionamido and butyrylamido; loweralkylthio, preferably containing from 1 to 4 carbon atoms, e.g., methylthio, ethylthio, propylthio and butylthio; cycloloweralkyl, preferably containing from 5 to 7 carbon atoms, e.g., cyclopentyl, cyclohexyl and cycloheptyl; or an aromatic moiety of the formula Y is either a direct bond or a bridging member of the group oxygen; sulfur; imino; carbonyl; or a straight chain lo'weralkylene, preferably containing from 1 to 4 carbon atoms, e.g., methylene, ethylene and trimethylene;
X and X are the same or different and represent halogen, preferably having an atomic weight no greater than 80, i.e., fluorine, bromine or chlorine;
Z and Z are the same or different and represent loweralkyl, preferably containing from 1 to 4 carbon atoms, e.g., methyl, ethyl, propyl and butyl; or nitro; and
n and n are the same or different and represent a whole number of from 1 to 3, inclusive or A and B are both m-trifluoromethylphenyl.
The preferred compounds of the present invention are those compounds of structural Formula I wherein A and B are the same, e.g., bis-(p-chlorophenoxy)malonic acid.
The above compounds (I) are prepared by reacting a di-substituted malonic acid ester with barium hydroxide to form a barium salt of the free acid and then converting the latter to the free acid. This process may be illustrated as follows:
A and B are as defined above; and
R represents lower alkyl, preferably containing from 1 to 4 carbon atoms, e.g., methyl, ethyl, propyl, isopropyl, butyl and t-butyl.
The reaction of the malonic acid ester (II) with barium hydroxide is carried out in a suitable inert solvent system which is capable of solubilizing both the barium hydroxide and the malonic acid ester. Desirably, the solvent system is composed of a mixture of Water and an organic solvent containing such amounts of each as may be necessary to solubilize the barium hydroxide and malonic acid ester, respectively. The particular organic solvent employed is not critical and the selection thereof is dependent upon the degree of solubility of the particular malonic acid ester in said solvent. However, it is preferred to employ an organic solvent which is water-miscible. Suitable solvents include the lower alkanols, e.g., methanol and ethanol, and others, e.g., diethyl ether, dioxane and tetrahydrofuran. The temperature at which the reaction is carried out, however, is critical to the extent that elevated temperatures (i.e., above about 35 C.) should. not be employed. Preferably, the reaction is effected at ordinary room temperature (2025 C.) although lower temperatures can be utilized. The resulting insoluble barium salt can be readily recovered in conventional manner.
The malonic acid (I) is obtained by reacting the thusobtained barium salt with a strong acid at room temperature. This reaction is conveniently carried out in any suitable inert organic solvent such as a lower alkanol, e.g., methanol. Preferably, the solvent is one which is capable of solubilizing the free malonic acid and in which the barium salt, formed during the reaction with the strong acid, is insoluble. Desirably, the acid employed is a mineral acid, preferably sulfuric acid. Recovery of the free malonic acid is accomplished in conventional manner.
The malonic acid esters (II) employed as starting materials may be prepared by reacting an unsubstituted or appropriately substituted phenolate with an appropriately substituted malonic acid to form the corresponding substituted malonic acid ester derivative. The resulting product is then treated with a halogenating agent to form the corresponding a-halo-derivati've and the latter reacted with an appropriately substituted phenolate to form the desired product. This process may be represented strncturally as follows:
Step 1 Cl /I-Ialogenating Agent K Step 2 A-ONa Step 3 In the above formulae A, B and R" are as defined hereinabove, and Hal represents halogen, preferably chlorine or bromine.
As illustrated above, Step 1 of the process invovles the reaction of the phenolate or substituted phenolate with a chloromalonic acid ester to form the corresponding substituted malonic acid ester derivative. This reaction is conveniently carried out in a suitable inert organic solvent such as dimethylacetamide, diethylacetamide, dimethylformamide or tetramethylurea. Preferably the reaction is initially carried out at elevated temperatures up to about 80 C. and then allowed to continue at room temperature. The particular solvent employed is not critical. Similarly, the particular temperature employer is not critical provided it does not exceed about 80 C.
In Step 2 of the process, the substituted malonic acid ester derivative is halogenated employing conventional agents for this purpose. The preferred agent is bromine, however, other agents such as chlorine, N-bromo-succinimide or sulfuryl chloride can also be used. The halogenation is conveniently carried out in a suitable inert organic solvent such as a haloalkane for example, dichloromcthane, chloroform, carbon tetrachloride and the like. Preferably the reaction is initially carried out at room temperature and then allowed to continue at reflux temperature. However, neither the choice of solvent nor temperature employed is critical.
The last step of the process (Step 3 involves the reaction of the a-halo-derivative obtained in Step 2 With the appropriately substituted phenolate. This reaction is conveniently effected in a suitable inert organic solvent such as that employed in Step 1. Preferably this reaction is initially carried out at room temperature and then allowed to continue at elevated temperatures up to about C. However, as indicated in Step 1, the choice of solvent or temperature employed is not critical provided that with respect to the latter, it does not exceed about 80 C. The resulting malonic acid ester (II) is readily recoverable employing conventional techniques.
The above process can be utilized for the preparation of all of the starting compounds represented by structural Formula II. Furthermore, it should be noted that the phenolate reactants employed in Steps 1 and 3 can be interchanged, that is, the phenolate of Step 3 can be employed as the reactant in Step 1 and the phenolate of Step 1 can be used as the reactant in Step 3.
Various of the phenolates employed as reactants in the above process are known and can be prepared as described in the literature. As to the others which are not specifically known, they can be readily prepared by methods analogous to those described in the literature. In general, such compounds are prepared by reacting the appropriate phenol with commercially available sodium hydride. If such procedure is utilized, it is highly desirable that any oil associated with the sodum hydride be removed prior to using the same. This can readily be accomplished by washing with an inert, dry solvent such as petroleum ether.
Various of the malonic acid derivatives employed as reactants in Step E can likewise be prepared as described in the literature. Such others which are not described in the literature may be prepared in analogous manner.
The malonic acid esters of structural Formula H wherein A and B are the same may also be prepared by reacting an appropriately substituted phenolate with a dihalomalonic acid ester. This process may be illustrated structurally as follows:
wherein:
A is m-trifluoromethylphenyl R, X', Z, R", Hal and n are as defined hereinabove.
This reaction is readily carried out in an inert organic solvent such as employed in Step 1 of the previous process and at room temperature, or elevated temperatures up to about 80 C. However, the particular solvent or temperature employed is not critical provided that with respect to the latter, it does not exceed about 80 C. The resulting product (Ila) is readily recovered in conventional manner.
As previously indicated hereinabove, the phenolates employed in the above process can be prepared as described in the literature or in analogous manner. Similarly, the statement above regarding the preparation of the phenolates employing sodium hydride is equally applicable to the instant process. Various of the dihalomalonic acid esters employed are likewise known and can be prepared as described in the literature. Such others which are not specifically known can be prepared from available materials in analogous manner.
The compounds of structural Formula I are useful because they possess pharmacological activity. In particular the compounds are useful as hypocholesteremics/hypolipemics. For such usage the compounds may be admixed with conventional pharmaceutical carriers, and other adjuvants, if necessary, and administered orally in such forms as tablets, capsules, elixirs, suspensions or solutions. Furthermore, the compounds may be similarly administered in the form of their sodium or calcium salts. Such salts do not materially differ from the base in their pharmacological effects and are included within the scope of the invention. The salts are readily prepared by reacting the acid with an appropriate base in conventional manner. The dosage administered will, of course, vary depending on the compound employed. However, in general, satisfactory results are obtained when administered at a daily dosage of from about 1 gram to about 2 grams, preferably given in divided doses of from about 250 milligrams to about 1000 milligrams two to four times a day or in sustained release form. A representative formulation suitable for oral administration is a tablet prepared by standard tabletting techniques and containing (by weight) 50 parts of bis-(p-chlorophenoxy) malonic acid, 2 parts of tragacanth, 39.5 parts of lactose, 5 parts of corn starch, 3 parts of talcum and 0.5 part of magnesium stearate.
The following examples show the preparation of representative compounds contemplated by this invention. In the examples where parts and percentages are designated they are by weight unless otherwise specified, and the temperatures are in degrees centigrade. The relationship between parts by weight and parts by volume is the same as that between the kilogram and the liter. However, it is to be understood that these examples are intended for purposes of illustration only and are not intended as in any way limiting the scope of the invention which is defined in the appended claims.
EXAMPLE 1 Bis-(p-chlorophenoxy)malonic acid 0 (HQ-O l-OH Step A: Preparation of bis-(p-chlorophenoxy)malonic acid diethyl ester.-Wash 43.3 parts (1.0 mole) of 5.7% sodium hydride in mineral oil with dry, low boiling petroleum ether. Then suspend the washed sodium hydride in 1500 parts by volume of dimethylacetamide and cool the obtained suspension to 0. Add 141.4 parts (1.10 moles) of p-chlorophenol to the thus-cooled suspension at such a rate that the temperature thereof does not exceed (external cooling with an ice/salt bath being employed as necessary).
After all of the p-chlorophenol is added, the mixture is stirred for an additional hour. Then remove the cooling bath, and add 159 parts (0.5 mole) of diethyldibromomalonate fairly rapidly allowing the temperature to rise to about 32.
Continue stirring for 88 hours. Then evaporate in vacuo of the solvent. Add 1500 parts by volume of ethylacetate to the resulting concentrate before washing same twice with 1500 parts by volume (each) of water and twice with 750 parts by volume (each) of 2 N (aq.) sodium hydroxide. Dry the thus-washed organic phase over anhydrous magnesium sulfate, filter the dried organic phase and evaporate the solvent contained in the obtained filtrate to produce the desired product.
Recrystallization from 95% ethanol affords bis-(pchlorophenoxy)-malonic acid diethyl ester, M.P. 48- 50 C.
Step B: Preparation of bis-(p-chlorophenoxy)malonic ac1d. Dissolve 16.1 parts (0.05 mole) of barium hydroxide in a mixture of 250 parts by volume of methanol and 20 parts by volume of Water, heated slightly (30 C.) on a water bath. To the practically-clear solution add a solution of 20.65 parts (0.05 mole) of bis-(p-chlorophenoxy)malonic acid diethyl ester in 50 parts by volume of methanol. A very thick, white suspension forms almost immediately. Keep the suspension on the water bath for 15 minutes, then filter off the solids (barium salt) and dry the same in an oven under high vacuum. Suspend 4.92 parts (0.01 mole) of the dried solids in 50 parts by volume of methanol and add thereto a solutlon of 1.025 parts of concentrated sulfuric acid in 10 parts by volume of water. Shake the resulting mixture for /2 hour, filter off the insoluble material and evaporate the filtrate at room temperature under high vacuum. Dissolve the resulting oil in 50 parts by volume of diethyl ether, dry the ether solution over magnesium sulfate and remove the solvent with a water aspirator. Crystallize the resulting oil from ethylacetate-cyclohexane and recrystallize the resulting solids from ethylacetate-cyclohexane to obtain bis-(p-chlorophenoxy)malonic acid, M.P. 159-160 C. (dec.).
EXAMPLE 2 Bis- (4-biphenylyloxy) malonic acid Step A: Preparation of bis-(4-biphenylyloxy)malonic acid diethyl esten-Wash 43.3 parts (1.0 mole) of 56.7% sodium hydride in mineral oil with dry, low boiling petroleum ether. Then suspend the washed sodium hydride in 1500 parts by volume of dimethylacetamide and cool the obtained suspension to 0. Add 187.2 parts (1.10 moles) of p-phenylphenol to the thus-cooled suspension at such a rate that the temperature thereof does not exceed 10 (external cooling with an ice/salt bath being employed as necessary).
After all of the p-phenylphenol is added, the formed suspension of the phenolate is stirred for an additional hour. Then remove the cooling bath, and add 159 parts (0.5 mole) of diethyldibromomalonate fairly rapidly to said formed suspension, allowing the temperature to rise about 32.
Continue stirring for 88 hours. Then evaporate in vacuo of the solvent. Add 1500 parts by volume of ethylacetate to the resulting concentrate before washing same twice with 1500 parts by volume (each) of water and twice with 750 parts by volume (each) of 2 N (aq.) sodium hydroxide. Separate organic layer and dry over magnesium sulfate. Filter and evaporate solvent to dryness. Add 500 cc. isopropyl ether to crystallize product; wash with cold isopropyl ether. Dry the thus-washed crystals at in vacuo for one hour to obtain bis-(4- biphenylyloxy)malonic acid diethyl ester, M.P. 107- 108.5 C.
Step B: Preparation of bis-(4-biphenylyloxy)malonic acid.Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(4-biphenylyloxy)malonic acid diethyl ester in place of the bis-(pchlorophenoxy).malonic acid diethyl ester used therein, there is obtained the product 'bis-(4-biphenylyloxy)malonic acid.
7 EXAMPLE 3 Bis- (p-bromophenoxy malonic acid Step A: Preparation of bis-(p-bromophenoxy)malonic acid diethyl ester.FolloWing the procedure of Step A of Example 1 and employing an equivalent amount of pbromophenol in place of the p-chlorophenol used therein, there is obtained the product bis-(p-bromophenoxy) malonic acid diethyl ester, M.P. 73-75" C.
Step B: Preparation of bis-(p-bromophenoxy)malonic acid.-Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(p-brornophenoxy)malo nic acid diethyl ester in place of the bis- (p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(p-bromophenoxy) malonic acid.
EXAMPLE 4 Bis-(p-fiuorophenoxy)malonic acid Step A: Preparation of bis-(p-fluorophenoxy)malonic acid diethyl ester.Following the procedure of Step A of Example 1 and employing an equivalent of p-fluorophenol in place of the p-chlorophenol used therein, there is obtained the product bis-(p-fluorophenoxy)malonic acid diethyl ester, M.P. 5051.5 C.
Step B: Preparation of bis-(p-fluorophenoxy)malonic acid.Following the procedure of Step B of Example 1 and employing an equivalent amount of bis-(p-fluorophenoxy)malonic acid diethyl ester in place of the bis-(pchlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(p-fluorophenoxy)malonic acid.
EXAMPLE 5 Bis- (m-chlorophenoxy malonic acid Step A: Preparation of bis-(m-chlorophenoxy)malonic acid diethyl ester.Following the procedure of Step A of Example 1 and employing an equivalent amount of m-chlorophenol in place of the p-chlorophenol used therein, there is obtained the product bis-(m-chlorophenoxy)malonic acid diethyl ester, B.P. 120 C./0.015
Step B: Preparation of bis-(m-chlorophenoxy)malonic acid.FolloWing the procedure of Step B of Example 1 and employing an equivalent amount of bis-(m-chlorophenoxy)malonic acid diethyl ester in place of the bis- (p-chlorophenoxy)malonic acid diethyl ester used there in, there is obtained the product bis-(m-chlorophenoxy)- malonic acid.
8 EXAMPLE 6 Bis-(3,4-dichlorophenoxy)malonic acid Step A: Preparation of bis-(3,4-dich1orophen0xy) malonic acid acid diethyl ester.FolloWing the procedure of Step A of Example 1 and employing an equivalent amount of 3,4-dichlorophenol in place of the p-chlorophenol used therein, there is obtained the product bis- (3,4-dichlorophenoxy)malonic acid diethyl ester, M.P. 96 C.
Step B: Preparation of bis-(3,4-dichlorophenoxy) malonic acid-Following the procedure of Step B of Example 1 and employing an equivalent amount of bis- (3,4-dichlorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis-(3,4- dichlorophenoxy)malonic acid.
EXAMPLE 7 Bis- (o-chlorophenoxy malonic acid Step A: Preparation of bis-(o-chlorophenoxy)malonic acid diethyl ester.Following the procedure of Step A of Example 1 and employing an equivalent amount of o-chlorophenol in place of the p-chlorophenol used therein, there is obtained the product bis-(o-chlorophenoxy) malonic acid diethyl ester, M.P. 111 C.
Step B: Preparation of bis-(o-chlorophenoxy)malonic acid.FolloWing the procedure of Step B of Example 1 and employing an equivalent amount of bis-(o-chlorophenoxy)malonic acid diethyl ester in place of the his- (p-ch1orophenoxy)malonic acid diethyl ester used therein, there is obtained the product bis(o-chlorophenoxy) malonic acid, M.P. 143 C. (dec.).
EXAMPLE 8 Bis-(2,4-dichlorophenoxy)malonic acid product bis-(2,4-dichlorophenoxy)malonic acid, M.P. 154 C. (dec.).
9 EXAMPLE 9 Bis-(4-chloro-2-methylphenoxy malonic acid EXAMPLE 10 Following the procedure of Step B of Example 1 and employing an equivalent amount of the malonic acid esters enumerated below in place of the bis-(p-chlorophenoxy) malonic acid diethyl ester used therein, there are obtained the malonic acids set forth below.
Malonic acid ester Malonic acid (a) Bis-(p-trifluoromethylphenoxy) Bis-(p-trifluoromethylphenoxy) malonic acid diethyl ester. malonic acid.
(b) Bis-(p-benzoylphenoxy) Bis-(p-benzoylphenoxy)malonic malonic acid diethyl ester. acid.
() Bis-(p-aeetamidophenoxy) Bis-(p-acetamidophenoxy)malonic malonic acid diethyl ester. acid.
((1) Bis-(p-benzy1pheu0xy)mal0nic Bis-(p-benzylphen0xy)malonic acid diethyl ester. acid.
(e) Bis-(4-chloro-2-nitrophenoxy) Bis-(4-chloro-2-nitrophenoxy) malonio acid diethyl ester. malonic acid.
(f) Bis-(2.5-dichlorophenoxy) Bis-(2,5-diehlorophenoxy)malonic malonic acid diethyl ester. ac
(g) Bis-(2,3-dichlorophenoxy) Bis-(2,3-dieh1orophenoxy)malonic malonic acid diethyl ester. acid. (11) Brs-(m-trifluoromethylphenoxy) Bis-(m-trifluorornethylphenoxy) ma1onic acid diethyl ester. malonic acid. (1) Bis-(3,5dichlorophenoxy) Bis-(3,5-dichloropheuoxy)malonic malonic acid diethyl ester. acid.
The above enumerated esters are prepared following the procedure of Step A of Example 1 and employing an equivalent amount of the phenols set forth below in place of the p-chlorophenol used therein.
(a) p-trifiuoromethylphenol (b) p-benzoylphenol (c) p-acetamidophenol (cl) p-benzylphenol (e) 4-chloro-2-nitrophenol (f) 2,5-dichloropheno1 (g) 2,3-dichlorophenol (h) m-trifiuoromethylphenol (i) 3,5-dichlorophenol.
EXAMPLE I1 (4-biphenylyloxy (p-chlorophenoxy malonic acid Step A: Preparation of (4-biphenylyloxy)-(p-chlorophenoxy)malonic acid diethyl ester.( a) Sodium hydride (56.7% in mineral oil), 47 g. (1.0 mole) is washed free from mineral oil with low boiling petroleum ether and suspended in 750 ml. of dimethylacetamide. To the suspension is added 129 g. (1.0 mole) of p-chlor0phenol in 500 ml. of dimethylacetamide in a manner so as to maintain the temperature of the mixture at about 10 to 20 C. The mixture is then stirred for two hours, 195 g. (1.0 mole) of diethylchloromalonate added, and the resulting mixture stirred at C. for five hours and then at room temperature for 72 hours. The resulting mixture is then poured over 2 liters of ice water, extracted with 750 ml. of isopropyl ether and the separated organic layer extracted with cold 1 N sodium hydroxide. The organic layer is then dried over anhydrous sodium sulfate, filtered and evaporated to yield (p-chlorophenoxy)malonic acid diethyl ester.
Recrystallization from petroleum ether at 60 C. affords product, M.P. 4446 C.
(b) To 1 liter of carbon tetrachloride is added 170 g. (0.59 mole) of (p-chlorophenoxy)malonic acid diethyl ester. While stirring at room temperature, 94.2 g. (0.59 mole) of bromine is added dropwise and the mixture stirred for 17 hours at room temperature and then at reflux for 2 hours. The mixture is then washed with 500 ml. of water and then 100 ml. of cold 10% aqueous soduim bicarbonate. The organic layer is then separated, dried over anhydrous sodium sulfate and evaporated to yield a-bromo-p-chlorophenoxy-malonic acid diethyl ester. Fractionation affords product, B.P. 131 C./.05 mm.
(c) To 200 ml. of dimethylacetamide is added 17 g. (0.1 mole) of p-phenylphenol and the resulting mixture added dropwise, with stirring, to a suspension of 4.6 g. (0.1 mole) of 56.7% sodium hydride (previously washed free of mineral oil with petroleum ether) in 100 ml. of dimethylacetamide. The resulting mixture is stirred at room temperature for minutes and 36.5 g. (0.1 mole) of a-bromo-p-chlorophenoxy-malonic acid diethyl ester in 50 ml. of dimethylacetamide is added in several portions. The mixture is then stirred with 1 g. of potassium iodide at room temperature for 72 hours, then at 50 C. for 30 minutes and then poured over 1500 ml. of ice water, and extracted with 500 ml. of isopropyl ether. The ether layer is then extracted with ml. of cold 1 N sodium hydroxide, dried over anhydrous sodium sulphate, filtered and evaporated to yield (4-biphenylyloxy)-(p-chl0ro phenoxy)malonic acid diethyl ester, M.P. 7981 C.
Step B: Preparation of (4-biphenylyloxy)-(p-chl0rophenoxy malonic acid.-F0l0wing the procedure of Step B of Example 1 and employing an equivalent amount of (4-biphenylyloxy)- (p-chlorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester used therein, there is obtained the product (4-biphenylyloxy) p-chlorophenoxy) malonic acid.
EXAMPLE 12 (p-Chlorophenoxy)-(p-bromophenoxy)malonic acid 1 1 EXAMPLE 13 (p-Chlorophenoxy)-(p-fluorophenoxy) malonic acid Step A: Preparation of (p-chlorophenoxy)-(p-fluorophenoxy)malonic acid diethyl ester.Following the procedure of Step A of Example 11 and employing an equivalent amount of p-fluorophenol in place of the p-phenylphenol used therein, there is obtained the product (pchlorophenoxy) (p-fluorophenoxy)malonic acid diethyl ester, B.P. 160 C./0.25 mm. Crystallization from petroleum ether affords crystalline product, M.P. 40-41 C.
Step B: Preparation of (p-chlorophenoxy)-(pfluorophenoxy)malonic acid.--Following the procedure of Step B of Example 1 and employing an equivalent of (pchlorophenoxy) (p-fluorophenoxy)malonic acid diethyl ester in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester, there is obtained the product (p-chlorophenoxy) (p-fluorophenoxy) malonic acid.
EXAMPLE 14 Following the procedure of Step B of Example 1 and employing an equivalent amount of the malonic acid esters enumerated below in place of the bis-(p-chlorophenoxy)malonic acid diethyl ester used therein, there are obtained the malonic acids set forth below:
Malonic acid Bis-[p-(phenylthio)phenoxy]- Malonic acid ester (a) Bis-[p-(phenylthio)phenoxy]- malonic acid diethyl ester. malomc acid.
(b) Bis-(p-anilinophenoxy)malonic Bis-(p-ani1inophen0xy)malonic acid diethyl ester. aci
(c) Bis-[p-(methylthio)phenoxy1- Bis-[p-(methylthio)phenox1y]- malonic acid diethyl ester. malonic acid.
The above enumerated esters are prepared following the procedure of Step A of Example 1 and employing an equivalent amount of the phenols set forth below in place of the p-chlorophenol used therein.
(a) p-(phenylthio)phenol (b) p-(anilino)pheno1 (c) p- (methylthio) phenol.
What is claimed is: 1. A compound of the formula wherein: A is either m-trifluoromethylphenyl,
(XI) I X represents halogen;
wherein:
Y is either a direct bond or a bridging member of the group oxygen, sulfur, imino, carbonyl or straight chain alkylene, having from 1 to 4 carbon atoms;]
B is either the same as A; or B is When A is either wherein X and n are as defined above, and X represents halogen which is unlike X.
2. A compound of claim 1 wherein A is the same as B. 3. A compound of claim 1 wherein B is when A is 4. A compound of claim 1 wherein B is when A is 5. A compound of claim 1 wherein A and B are as defined in claim 1 with the provision that any of X and X represents halogen having an atomic weight of no greater than 80.
6. A compound of claim 2, wherein A and B are as defined in claim 1, with the provision that X' represents halogen having an atomic weight no greater than 80.
7. A compound of claim 3 wherein n is as defined in claim 1, with the provision that any of X and X represents halogen having an atomic weight no greater than 80.
8. A compound of claim 4 wherein n is as defined in claim 1, with the provision that X represents halogen having an atomic weight no greater than 80.
9. A compound of claim 2 which is bis-(p-benzylphenoxy)malonic acid, bis-(p-acetamidophenoxy)malonic acid, or bis-(p-benzoylphenoxy)malonic acid.
10. A compound of claim 2 which is bis-(p-fluorophenoxy)malonic acid, bis-(o chlorophenoxy)malonic acid, bis-(2,5-dichlorophenoxy)malonic acid, bis-(2,3- dichlorophenoxy) malonic acid and bis-(3,5-dichlorophenoxy)malonic acid.
11. A compound of claim 2 which is bis-(4-chloro-2- nitrophenoxy)malonic acid, or bis-(4-chloro-2-methylphenoxy)malonic acid.
12. Bis- (4-biphenylyloxy)malonic acid.
13. Bis-(p-chlorophenoxy)malonic acid.
14. Bis-(p-bromophenoxy)malonic acid.
15. (4-biphenylyl0xy)-(p-chlorophenoxy)malonic acid.
. (p Ch10rophenoxy)-(p bromophenoxy)ma1onic (p Ch1or0phen0xy)-(p fiuor0phenoxy)malonic Bis-(3,4-dich1orophenoxy)malonic acid.
. Bis-(m-ch1or0phen0xy)malonic acid.
. Bis-(p-trifluoromethylphenoxy)malonic acid. Bis-(m-trifluoromethylphcnoxy)malonic acid. Bis-(2,4-dichlorophenoxy)malonic acid.
14 References Cited Niederl et a1.: JACS, 62, 1154 (1940). Conrad et a1.: Berichte, 24, 3004 (1891).
5 LORRAINE A. WEINBERGER, Primary Examiner DENNIS E. STENZEL, Assistant Examiner US. Cl. X.R.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51945966A | 1966-01-10 | 1966-01-10 | |
| US52993466A | 1966-02-25 | 1966-02-25 | |
| US54777166A | 1966-05-05 | 1966-05-05 | |
| US56957866A | 1966-08-02 | 1966-08-02 | |
| US57076566A | 1966-08-02 | 1966-08-02 | |
| US57755966A | 1966-08-02 | 1966-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3507911A true US3507911A (en) | 1970-04-21 |
Family
ID=27560091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US569578A Expired - Lifetime US3474128A (en) | 1966-01-10 | 1966-08-02 | Derivatives of malonic acid |
| US577559A Expired - Lifetime US3507911A (en) | 1966-01-10 | 1966-08-02 | Di-substituted malonic acids |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US569578A Expired - Lifetime US3474128A (en) | 1966-01-10 | 1966-08-02 | Derivatives of malonic acid |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US3474128A (en) |
| CH (1) | CH481047A (en) |
| DE (1) | DE1593971A1 (en) |
| ES (4) | ES335390A1 (en) |
| FR (1) | FR6302M (en) |
| GB (2) | GB1177841A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3699150A (en) * | 1970-05-22 | 1972-10-17 | Baychem Corp | Ethers of dicarboxylic acids |
| US4008265A (en) * | 1971-05-22 | 1977-02-15 | Sumitomo Chemical Company, Limited | Novel bisphenoxy carboxylic acid derivatives and their salts |
| US3928602A (en) * | 1972-11-01 | 1975-12-23 | Astra Laekemedel Ab | Substituted phenoxymalonic acids, esters thereof and hypolipaemic agents containing the same for lowering lipid levels |
| DE2362416A1 (en) * | 1973-12-15 | 1975-06-19 | Merck Patent Gmbh | DIPHENOXYACIC ACID DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
| EP0004317B1 (en) * | 1978-03-17 | 1982-01-06 | Ciba-Geigy Ag | Derivatives of phenoxy-alkanecarboxylic acids, their preparation, weed-killing products containing them and their use |
-
1966
- 1966-08-02 US US569578A patent/US3474128A/en not_active Expired - Lifetime
- 1966-08-02 US US577559A patent/US3507911A/en not_active Expired - Lifetime
- 1966-12-23 CH CH1848866A patent/CH481047A/en not_active IP Right Cessation
-
1967
- 1967-01-05 GB GB684/67A patent/GB1177841A/en not_active Expired
- 1967-01-05 GB GB36616/69A patent/GB1177842A/en not_active Expired
- 1967-01-07 DE DE19671593971 patent/DE1593971A1/en active Pending
- 1967-01-09 ES ES335390A patent/ES335390A1/en not_active Expired
- 1967-01-09 ES ES335393A patent/ES335393A1/en not_active Expired
- 1967-01-09 ES ES335392A patent/ES335392A1/en not_active Expired
- 1967-01-09 ES ES335391A patent/ES335391A1/en not_active Expired
- 1967-04-07 FR FR101957A patent/FR6302M/fr not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| None * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1177842A (en) | 1970-01-14 |
| US3474128A (en) | 1969-10-21 |
| ES335392A1 (en) | 1968-03-16 |
| ES335390A1 (en) | 1968-03-16 |
| DE1593971A1 (en) | 1970-08-20 |
| ES335391A1 (en) | 1968-03-16 |
| FR6302M (en) | 1968-09-09 |
| ES335393A1 (en) | 1968-03-16 |
| CH481047A (en) | 1969-11-15 |
| GB1177841A (en) | 1970-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3668241A (en) | Substituted 1-oxoinden-5-yloxy alkanoic acids | |
| US4070539A (en) | [1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid | |
| US4191776A (en) | Biphenyl derivatives | |
| US3507911A (en) | Di-substituted malonic acids | |
| US3763229A (en) | Indan-1-carboxylic acid derivatives | |
| US4024182A (en) | Preparation of aryl-butadienoic acids | |
| US4683331A (en) | Omega-(2,4-dihalobiphenylyl) oxo alkanoic acids | |
| US3546229A (en) | Derivatives of acetic acid | |
| US3558645A (en) | 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids | |
| US3564042A (en) | Derivatives of acetic acid | |
| US3539628A (en) | Derivatives of acetic acid | |
| US3880932A (en) | 4-(2-Naphthyl)-4-alkyl-3-buten-2-ones | |
| US3454581A (en) | Derivatives of bis-(p-chlorophenoxy) acetic acid | |
| US3526632A (en) | Derivatives of bis-(4-biphenylyloxy)acetic acid | |
| US3396164A (en) | Naphthoxazinones | |
| US3458563A (en) | ((3 - (hydrocarbylpolythio)alkanoyl)phenoxy)alkanoic acids and ((3-(hydrocarbylpolythio)alkanoyl)phenylthio)alkanoic acids | |
| US3558626A (en) | 2-(4 - (diphenyl-2-pyrimidinyl)phenoxy) lower aliphatic monocarbocyclic acids and esters | |
| US3884961A (en) | Bis-(substituted benzyl) malonic acid esters | |
| US3275689A (en) | 3-alkylsulfonyl-5-(tertiaryaminopropylidene)-and 5-hydroxy-5-(tertiaryaminopropyl)-5h-dibenzo[a, d] cycloheptenes | |
| US3462473A (en) | Phenoxyphenyl alkanesulfonates | |
| FI58629C (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN HYPOKOLESTEROLEMISKT OCH HYPOTRIGLYSERIDEMISKT AKTIV FOERENING | |
| US3660579A (en) | Derivatives of acetic acid in compositions and methods for the alleviation of hyperlipemia | |
| US3542795A (en) | Di-bis(p-chlorophenoxy) acetic acid esters of dimethylol pyridines | |
| US3322821A (en) | Process for converting [4-[2-(organosulfinylmethyl)alkanoyl]phenoxy]alkanoic acids and [4-[2-(organosulfonylmethyl)alkanoyl]phenoxy]alkanoic acids to their [4-(2-methylenealkanoyl)phenoxy]alkanoic acid derivatives | |
| US3574849A (en) | Bis-(p-chlorophenoxy)acetic acid in compositions and methods for treating hypercholesteremia |